Cholesterol Ratio Calculator
Enter your lipid panel to calculate Total Cholesterol to HDL, LDL to HDL, and Triglycerides to HDL ratios — plus the Atherogenic Index of Plasma — with category badges and reference cutoffs drawn from published consensus thresholds. Wellness reference, not a diagnostic tool.
Cutoffs drawn from NCEP ATP III, ACC/AHA 2018 lipid guidance, Salazar MR et al. (2013) for TG/HDL, and Dobiasova & Frohlich (2001) for the Atherogenic Index. Reference ranges vary by laboratory and population; always discuss results with your healthcare provider.
Why Cholesterol Ratios Matter
A standard lipid panel returns four numbers — Total Cholesterol, HDL, LDL, and Triglycerides — and most people focus on LDL alone. That is understandable: LDL cholesterol is the primary target of statin therapy in the ACC/AHA 2018 cholesterol guideline and the ESC/EAS 2019 dyslipidaemia guidelines. But research suggests that ratios capture additional information beyond any single number, because they reflect the balance between atherogenic lipoproteins (LDL, VLDL, remnants) and protective HDL, and between triglyceride-rich particles and HDL.
Someone with an LDL of 130 mg/dL and an HDL of 70 mg/dL shows a notably different lipid profile from someone with the same LDL but an HDL of 30 mg/dL. The second person has a TC/HDL ratio roughly twice as high, reflecting a different lipid balance even though their LDL prints the same on the report. These ratios are educational reference numbers; clinical cardiovascular risk assessment requires the Pooled Cohort Equation or equivalent and a clinician.
The Three Core Ratios
| Ratio | Within typical | Upper end of typical | Above typical | Significantly above typical |
|---|---|---|---|---|
| Total Cholesterol / HDL | < 3.5 | 3.5 – 5.0 | 5.0 – 9.6 | > 9.6 |
| LDL / HDL | < 2.5 | 2.5 – 3.5 | 3.5 – 5.0 | > 5.0 |
| Triglycerides / HDL (mg/dL) | < 2 | 2 – 3 | 3 – 4 | > 4 |
| Triglycerides / HDL (mmol/L) | < 0.87 | 0.87 – 1.33 | 1.33 – 1.74 | > 1.74 |
Cutoffs reflect commonly used consensus thresholds and published work (Castelli, 1988; Salazar MR et al., Am J Cardiol 2013). They are educational reference numbers, not replacement diagnoses for guideline-based risk scoring.
The Total Cholesterol to HDL Ratio
The TC/HDL ratio was popularised by the Framingham Heart Study investigators, notably William Castelli, as a simple integrator of two of the strongest lipid predictors: total cholesterol burden and the presence of protective HDL. Consensus thresholds typically suggest a ratio below 3.5 reflects a typical range, 3.5–5.0 the upper end of typical, and values above 5 above typical reference cutoffs in epidemiological work. Values above 9 reflect a notably elevated lipid balance and warrant follow-up with your healthcare provider.
The LDL to HDL Ratio
LDL/HDL isolates the two particles most directly implicated in plaque biology — LDL particles driving deposition into the arterial wall and HDL particles involved in reverse cholesterol transport. Studies indicate that values below 2.5 reflect a typical range, 2.5–3.5 the upper end of typical, and values above 3.5 are above typical reference cutoffs. For a person whose total cholesterol is elevated mostly because of high HDL, the LDL/HDL ratio helps separate protective from atherogenic contributions.
The Triglycerides to HDL Ratio
The TG/HDL ratio is the most metabolically interesting of the three because research suggests it is a simple surrogate associated with insulin resistance and the presence of small dense LDL particles. Salazar MR and colleagues reported in a 2013 American Journal of Cardiology paper that a TG/HDL cutoff of approximately 3.0 in mg/dL (about 1.33 in mmol/L) was associated with insulin resistance in middle-aged adults. Subsequent studies have replicated this, though cutoffs vary across populations and by sex, ethnicity, and age. A TG/HDL value above typical reference cutoffs may suggest metabolic factors worth tracking alongside fasting glucose, HbA1c, and insulin — values in this range warrant follow-up with your healthcare provider.
The Atherogenic Index of Plasma (AIP)
The Atherogenic Index of Plasma, introduced by Dobiasova and Frohlich in 2001, is defined as log10(TG / HDL), with both values in mmol/L. It was designed to correlate with the fraction of small dense LDL particles. Published interpretive bands typically suggest values below 0.11 reflect a typical range, 0.11 to 0.21 the upper end of typical, and above 0.21 above typical reference cutoffs. AIP is an academic marker rather than a clinical target, but it is commonly reported in lipidology research and is included here for completeness.
Non-HDL Cholesterol: A Useful Reference Number
Non-HDL cholesterol is calculated as Total Cholesterol minus HDL. It captures all atherogenic lipoproteins — LDL, IDL, VLDL and its remnants, and Lp(a) — in one number. The NCEP ATP III framework and subsequent guidelines (AHA/ACC, ESC/EAS) use non-HDL as a secondary lipid reference, with a commonly cited target of below 130 mg/dL (3.4 mmol/L) for average adults, and lower targets for individuals with other wellness factors. Non-HDL becomes particularly useful when triglycerides are elevated, because the Friedewald LDL estimate becomes less reliable above about 400 mg/dL (4.5 mmol/L).
Beyond Ratios: What Else Matters
Ratios are a helpful educational lens, but they do not replace comprehensive clinical assessment. For a fuller picture, clinicians typically consider:
- Apolipoprotein B (apoB) — counts atherogenic particles directly, one per LDL/IDL/VLDL/Lp(a); research increasingly suggests it is informative alongside LDL-C for many patients.
- Lipoprotein(a), or Lp(a) — a genetically determined LDL-like particle that studies indicate is an independent factor in cardiovascular research.
- High-sensitivity CRP (hs-CRP) — a marker of low-grade inflammation studied in cardiovascular research.
- HbA1c and fasting glucose — metabolic status influences how cholesterol behaves.
- Blood pressure — one of the largest modifiable contributors to cardiovascular events globally.
Ratios are best used as an educational reference and a wellness signal — not as a standalone risk score. For formal risk prediction, clinicians use validated calculators such as the ACC/AHA Pooled Cohort Equations or SCORE2 from the European Society of Cardiology, which combine lipids with age, sex, blood pressure, smoking, and diabetes.